Repros Therapeutics Inc Stock

Stocks

27/01/18	Repros Announces Negative Opinion From the EMA for Enclomiphene	GL
16/12/17	Repros Therapeutics Inc.® Receives Feedback Following an Oral Explanation with the European Medicines Agency	GL
13/12/17	REPROS THERAPEUTICS INC. Rigrodsky & Long, P.A. Announces Investigation of Buyout	BU
13/12/17	Levi & Korsinsky, LLP Reminds Investors of an Investigation Concerning Whether the Sale of Repros Therapeutics Inc. to Allergan plc is Fair to Shareholders	BU
12/12/17	Repros Therapeutics Inc.® Announces Acquisition by Allergan plc	GL

02/04/15	Apple : Les valeurs à suivre sur les marchés américains
02/04/15	USA-Les valeurs à suivre à Wall Street

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
REPROS THERAPEUTICS INC	-.--%	+0.74%	-	-	0
LONZA GROUP AG	+1.33%	-1.95%	-1.98%	+10.49%	46.86B
REVOLUTION MEDICINES, INC.	+1.90%	+7.54%	+420.64%	+670.72%	40.23B
BEONE MEDICINES AG	+0.91%	+6.32%	+12.12%	+57.61%	36.23B
IQVIA HOLDINGS INC.	+0.98%	+2.70%	+5.89%	-6.75%	34.72B
CELLTRION, INC.	+3.14%	+1.02%	+4.76%	+43.00%	27.89B
MEDPACE HOLDINGS, INC.	-1.11%	+14.00%	+32.84%	+141.82%	16.79B
ASCENDIS PHARMA A/S	+1.14%	+1.30%	-	-	16.74B
EUROFINS SCIENTIFIC SE	+0.60%	-6.02%	+2.14%	+7.60%	13.12B
ICON PUBLIC LIMITED COMPANY	+1.52%	-0.06%	-12.43%	-31.27%	12.7B
Average	+0.97%	+0.83%	+58.00%	+111.65%	27.25B
Weighted average by Cap.	+1.28%	+0.91%	+78.88%	+142.69%

Employees

Sector